Jumalon, Jesee C.

HRN: 28-01-02  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/26/2025
METRONIDAZOLE 500MG (TAB)
10/26/2025
11/02/2025
PO
500mg
TID
AMOEBIASIS
Checking Final Appropriateness 
10/28/2025
CEFTRIAXONE 1G (VIAL)
10/28/2025
11/04/2025
IV
2g
OD
Complicated UTI
Checking Final Appropriateness 
10/28/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/28/2025
11/04/2025
IV
500mg
Q8h
AMOEBIASIS
Checking Final Appropriateness 
10/31/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/31/2025
11/21/2025
IVTT
750mg
Q8h
Ameobiasis
Checking Final Appropriateness 
11/06/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/06/2025
11/06/2025
IV
750mg
Q8
Amoebiasis
Waiting Final Action 
11/06/2025
CIPROFLOXACIN 500MG (TAB)
11/06/2025
11/20/2025
PO
500mg
Bid
Abscess
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: